US20030129238A1 - Edible MCC/PGA coating composition - Google Patents
Edible MCC/PGA coating composition Download PDFInfo
- Publication number
- US20030129238A1 US20030129238A1 US10/306,649 US30664902A US2003129238A1 US 20030129238 A1 US20030129238 A1 US 20030129238A1 US 30664902 A US30664902 A US 30664902A US 2003129238 A1 US2003129238 A1 US 2003129238A1
- Authority
- US
- United States
- Prior art keywords
- coating composition
- coating
- weight
- propylene glycol
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
Definitions
- This invention relates to edible, hardenable coating compositions comprising microcrystalline cellulose (MCC), a film forming amount of propylene glycol alginate (PGA) and a strengthening polymer, optionally containing a plasticizer, a surface active agent, a filler, a coloring agent or a combination of such optional ingredients.
- MCC microcrystalline cellulose
- PGA propylene glycol alginate
- the coatings of the present invention can be applied to pharmaceutical, including neutraceutical, and veterinary solid dosage forms, such solid substrates such as seeds, animal feed, fertilizers, pesticide tablets and granules, and also to confectionery and foods. They are readily dispersed in aqueous media, and, when applied as a coating, provide high lustre coatings, which do not retard or extend release of active ingredient from a coated substrate.
- a pharmaceutical or veterinary tablet coating Another very important function of a pharmaceutical or veterinary tablet coating is to improve the integrity of the tablet itself. Uncoated tablets are often subject to being abraded or chipped, causing a loss of active ingredient in the process. More dramatically, they may break into two or more pieces. One measure of a useful coating is its ability to prevent any of these physical degradations of tablet structure. The effectiveness of a coating material to prevent abrading, chipping, or breakage of the tablet is determined by friability testing.
- Confectionery and foods may be coated with a formulation to preserve the confection or food from deteriorating by contact with the oxygen and the moisture in the atmosphere. Coatings also can provide improved appearance and desirable organoleptic properties to the food as well as preventing loss of flavor.
- Seeds may be coated to preserve the viability of the seeds by protecting against moisture. They may also be coated as a means for increasing particle size to facilitate mechanical planting.
- a dye can be included in the coating formulation to identify the seeds as to quality, type, or some other designation.
- a pesticide e.g., a fungicide
- this coating must not decrease the viability of the seeds or interfere with germination when the seeds are planted in the soil.
- Animal feed may be coated to improve its flowability, appearance and its resistance to powdering or dusting.
- the coating may be formulated to include vitamins, hormones, antibiotics, or the like, to benefit the livestock which will consume the feed.
- Fertilizers in either granular or tableted forms, may be coated to retain the integrity of the form and, especially, to protect the fertilizer from moisture which can cause agglomeration during storage, which could make rapid, even application to the soil difficult or inconvenient.
- Coating of tableted pesticide formulations serves to maintain the integrity of the tablets or granules until they are placed in water where they rapidly disintegrate, forming a solution or slurry to be applied to the soil or plants.
- a second, and equally important, function of the coatings on tablets containing pesticides is to prevent human contact with the pesticide, thereby increasing safety for those handling and applying the pesticide.
- the film-former In the preparation of a coating formulation to be sprayed, the film-former is usually dissolved or dispersed in a solvent, for example, water, along with the other ingredients of the formulation.
- a solvent for example, water
- the coating formulation must frequently be prepared in advance of the time it is to be applied to the tablets. A common procedure is to prepare these coating formulations the day preceding the coating operation in order to assure adequate hydration of the polymers used in them.
- a particular disadvantage of coatings based primarily on hydroxypropylmethylcellulose (HPMC) is that the coating may harden over time and therefore increase tablet disintegration times.
- An increase in disintegration time delays the bioavailability of the active ingredient at least in proportion to the increase in disintegration time.
- Many other agents commonly used in coating compositions are also known to delay release of pharmaceutical agents, such as enteric coatings which use polymeric film forming materials which are insoluble in water, or gastric fluid, some of these being specifically selected to by-pass both the stomach and small intestine and provide colonic release.
- the coatings of this invention meet U.S. Pharmacopeia standards for rapid or immediate dissolution (U.S.P. monograph 23) of active ingredients from tablets or other solid dosage forms coated with them. They provide prompt release or dissolution consistent with the release rates which is normally obtained with the uncoated tablets or other substrates. Thus, they do not adversely impact or retard release of active ingredients from a substrate coated with them. Further, the coatings of this invention are readily dispersed and rapidly hydrated in aqueous media for application to a coating substrate, and provide elegant coatings which have all the benefits of coatings now in commercial use without the drawbacks that are common to them.
- a coating composition which comprises a unique combination of materials specifically adapted for prompt release when placed in aqueous media or ingested.
- the coating composition of the present invention comprises microcrystalline cellulose, a film forming amount of propylene glycol alginate and a strengthening polymer, and may additionally contain a plasticizer, a surface active agent, a filler, a coloring agent or combination of these additional ingredients. More specifically, the present invention provides a prompt release, edible, hardenable coating composition, as well as dry coatings and aqueous dispersions thereof and solid dosage forms coated therewith.
- the term “edible” is intended to mean food grade materials which are approved by regulatory authorities for use in pharmaceutical or food applications.
- the term “hardenable,” used to describe the coating compositions of this invention is intended to include only those coating compositions that are capable of being dried from an aqueous solution or dispersion thereof into a solid coating which resists abrasive forces, i.e. a hardened coating, as distinguished from those “enrobing” coatings on confections which set up into a soft coating that can be handled and packaged but which do not resist abrasive forces significantly.
- immediate means that the coatings of this invention meet U.S. Pharmacopeia standards (U.S.P. monograph 23) for rapid or immediate dissolution of active ingredients from tablets or other solid dosage forms coated with them.
- U.S. Pharmacopeia standards U.S.P. monograph 23
- they provide prompt release or dissolution consistent with the release rates which is normally obtained with the uncoated tablets or other substrate. They do not, when placed in water or ingested, adversely impact or retard release or dissolution of tablets or other dosage forms coated with them.
- Coatings made in accordance with the present invention are substantially or completely disintegrated and/or dissolved within less than 10 minutes after being ingested or placed in aqueous media.
- microcrystalline cellulose simply blended with propylene glycol alginate, provides important film characteristics required to provide an elegant coating which is particularly useful in, for example, coating pharmaceutical and veterinary tablets, caplets, granules, and spheres which contain active ingredients which require release promptly after being placed in aqueous media or ingested.
- Microcrystalline cellulose is a purified, partially depolymerized cellulose that is generally produced by treating a source of cellulose, preferably alpha cellulose in the form of a pulp from fibrous plants, with a mineral acid, preferably hydrochloric acid. The acid selectively attacks the less ordered regions of the cellulose polymer chain, thereby exposing and freeing the crystallite sites, forming the crystallite aggregates which constitute microcrystalline cellulose. These are then separated from the reaction mixture and washed to remove degraded by-products. The resulting wet mass, generally containing 40 to 60
- a film forming amount of propylene glycol alginate may be in the range of about 10% to about 50%, more specifically about 12% to about 50%, by dry weight of the coating composition.
- the propylene glycol alginate employed in the present invention may vary widely in viscosity.
- a typical high viscosity propylene glycol alginate is such that a 2% aqueous solution thereof has a viscosity in the range of 700 to 1800 mPa ⁇ s at 25° C., and is commercially available as Protonalg ester SD-LB, Pronova/FMC Corporation.
- a typical low viscosity propylene glycol alginate is such that a 2% aqueous solution thereof has a viscosity in the range of 20-30 mPs ⁇ s at 25° C., and is commercially available as Profoam®, Pronova/FMC Corporation.
- High viscosity propylene glycol alginate is generally employed in a lower amount than that employed for low viscosity material, typically in the range of 10% to about 20% by dry weight of the coating composition, as illustrated in examples 1-6 below.
- Use of substantially higher amounts of high viscosity propylene glycol alginate may result in coating solutions which are too viscous, tend to plug coating equipment, and may not flow sufficiently to form a satisfactory coating.
- Low viscosity propylene glycol alginate conversely is generally used in a higher amount, typically in the range of 20% to 50% by dry weight of the coating composition, as illustrated in examples 7 through 30.
- Propylene glycol alginate may be used in combination with other film forming materials, for example, carrageenan and cellulosic polymers such as HPMC and hydroxypropylcellulose.
- Carrageenan preferably iota carrageenan
- Carrageenan may suitably be employed as a multifunctional component in combination with propylene glycol alginate at a concentration in the range of about 3% to about 20% of the dry weight of the coating composition.
- carrageenan When carrageenan is employed in the composition at a concentration in the range of about 3% to about 8%, it is believed to serve primarily to improve the gloss of the resulting coating, that is, as a gloss enhancer.
- the weight ratio of propylene glycol alginate to carrageenan is suitably in the range of about 2:1 to about 10:1.
- Carrageenan may also be used at a level above about 9%, for example, at a concentration in the range of about 9% to about 20%, more specifically in the range of 10% to about 15%. At these levels it is believed to serve not only to improve gloss of the coating, but also to contribute film forming properties and to contribute to the strength and integrity of the resulting film coating.
- carrageenan may be viewed to function as a co-film-former or as a supplemental or secondary film-former in the coating compositions.
- Such a weight ratio of propylene glycol alginate to carrageenan may be in the range of 2:1 to about 0.8:1.
- propylene glycol alginate when the weight ratio of propylene glycol alginate to carrageenan is in the range of about 1.5:1 to about 2:1, propylene glycol alginate may be considered to be the primary film-former and carrageenan the secondary film-former, as illustrated in examples 18 through 21 and 25 through 30.
- propylene glycol alginate and carrageenan when approximately equal amounts of propylene glycol alginate and carrageenan are employed, that is, when the propylene glycol alginate to carrageenan weight ratio is, for example, in the range of about 1:0.8 to about 1:1.2, each of them may be considered to contribute relatively equal film forming properties to the resulting film coating, thus are considered to be co-film-formers as illustrated by examples 18 and 20-24.
- the weight ratio of microcrystalline cellulose to propylene glycol alginate in the compositions of this invention may vary depending on the application, but generally range from about 90:10 to about 20:80, more specifically from about 80:20 to about 20:80.
- a particular advantage for the dry, physical blends is that the ratio can be easily changed by simple blending techniques rather than manufacturing different ratios of a coprocessed material. Thus, the dry, physical blends provide great flexibility for specific applications having different requirements.
- a dry, physical blend of microcrystalline cellulose and a film forming amount of propylene glycol alginate, a strengthening polymer, preferably, hydroxyethylcellulose (HEC), are present in the coating formulation of this invention, advantageously in combination with other optional ingredients such as a plasticizer, a surfactant, a filler or a coloring agent, other conventional excipients or combinations thereof.
- HEC hydroxyethylcellulose
- Other strengthening polymers which can provide the same benefit and may be used instead of HEC include HPMC, hydroxypropylcellulose, ethylcellulose, methylcellulose and polyvinylpyrrolidone (PVP), however care must be exercised in the use of such alternative materials to avoid retarding release of active ingredients and/or bioavailability.
- the preferred amount of strengthening polymer is less than the total amount of microcrystalline cellulose and propylene glycol alginate present in the composition.
- the strengthening polymer may be employed in the composition at a level of about 0.5% to about 30%, advantageously about 5% to 30% to provide strength and improved appearance to the coating.
- This strength can be demonstrated by casting films of coating formulations on a flat, non-adherent surface, cutting strips of uniform width from the casting, and subjecting the strips to tensile testing on, for example, an Instron Tensile Tester. The results of these tests show a very significant increase in tensile strength and decreased brittleness of the film when HEC or another strengthening polymer is included in the formulation.
- Strengthening polymers suitable for use in this invention are those polymers having a viscosity equal to or less than 20 mPa ⁇ s in a 2% aqueous solution at 20° C.
- a strengthening polymer is employed in the composition in absence of a plasticizer, it is generally employed at about 15% to about 30% by dry weight coating composition, and HEC is preferably employed at about 20% to about 25% by dry weight of the formulation.
- compositions of this invention may also contain at least one of a plasticizer, a surfactant, a filler, a coloring agent or a combination of these additional components of the composition.
- a conventional plasticizer may also be included in the coating composition.
- Suitable plasticizers include polyethylene glycol, triacetin, dibutyl sebacate, propylene glycol, sorbitol, glycerin, and triethyl citrate. Of these, triacetin is preferred.
- These plasticizers may be employed in the coating compositions of the invention at about 18% to about 36% by dry weight of the coating composition, advantageously about 20% to about 30% by dry weight of the coating composition.
- Fillers suitable for use in the compositions of the invention include, for example, calcium carbonate, dicalcium phosphate and carbohydrates, such as starch, maltodextrin, lactose, mannitol and other sugars or croscarmellose sodium. Of these, mannitol or maltodextrin is a preferred filler.
- Surfactants which are either anionic or nonionic may be used beneficially in the edible, hardenable coating compositions of the present invention.
- Useful surfactants may be, for example, sodium lauryl sulfate, hydroxylated soy lecithin, polysorbates, and block copolymers of propylene oxide and ethylene oxide.
- Coloring agents and opacifiers which may be used in these coatings or added to a suspension thereof include aluminum lakes, insoluble pigments, water soluble dyes, titanium dioxide, and talc.
- Stearic acid or a salt or ester thereof may be included at a level of about 1% to about 5% by dry weight of the compositions to increase gloss of the coating, particularly when a plasticizer is not employed in the composition.
- a coating formulation of this invention may be sold as a dry powder formulation or as a ready-to-use dispersion in water.
- aqueous dispersions it is preferred that these be prepared under aseptic conditions. Heating the water to an elevated temperature, for example, 85° C., prior to preparation of the dispersion has shown that bacteria, mold, and yeast growth are prevented for at least 48 hours on agar pour plates. Therefore, if the containers for the dispersion are properly sanitized and then kept closed after being filled until the dispersion is used, there is little likelihood of bacteria, mold, or yeast growing in the dispersion.
- a preservative may be added.
- a combination of methyl and/or propyl paraben has been found to be useful in this regard.
- the composition of this invention comprises from about 15% to about 50% of microcrystalline cellulose, about 10% to about 50% by weight of propylene glycol alginate, and about 5% to about 25% of strengthening polymer. If a plasticizer is employed, it is advantageously used at about 20% to about 30% by weight of the composition.
- the composition of the invention may also include an inert filler at about 2% to about 28% by weight.
- about 1% to about 30% by weight of the formulation may comprise edible coloring agents and opacificiers such as talc or titanium dioxide, including from 1% to about 8% of coloring component such as a food dye or pigment, preferably about 1% to about 3%.
- a surfactant at about 0.5% to about 10%, advantageously 0.5 to about 7%, preferably 1.25% to 3% when a filler such as mannitol is present.
- a filler such as mannitol
- surfactants such as lecithin may be employed at a level of about 3% to about 20%.
- Preservatives such as methyl paraben at 0.75% to 1.50% and/or propyl paraben at 0.075% to 0.15% may also be present in the formulation.
- the viscosity of the hydrated formulation can be important. It ideally should be low enough to be pumped to a spray unit continuously and then sprayed evenly in a useful pattern onto the substrate being coated.
- a useful concentration of the dry ingredients in water on a weight percentage basis therefore, may be about 6% to about 15%, advantageously 6.5% to 11%, preferably about 8% to about 11%.
- the preferred edible, hardenable, prompt release coating formulations of this invention may generally be prepared and used according to a simple procedure.
- a dry blend of microcrystalline cellulose and propylene glycol alginate, and a strengthening polymer, such as hydroxyethylcellulose, and optionally at least one additional ingredient, such as polyethylene glycol or other acceptable plasticizer, optionally together with a solid filler such as maltodextrin, lactose, mannitol or the like, preservatives, and/or surfactants are blended to form dry coating composition.
- Addition of edible coloring agents for example, a water soluble dye or a pigment, may precede the hydration step required to prepare the final coating formulation.
- This dry mixture is then added slowly to the vortex of stirred, purified water. Stirring of this mixture is continued for a sufficient period to allow all of the components to be fully hydrated. If a colored coating material is required a water soluble dye or a pigment may also be added, preferably as a dispersion or solution, to the hydrated coating composition. Optionally surfactants, and/or plasticizers may also be added at this stage of the process.
- a simple propeller mixer provides adequate agitation for rapid hydration.
- the period of hydration may be as short as 0.5 hours. It may, and preferably should, be longer, but more than 3 hours is not believed to be necessary.
- Hydration can take place at room temperature or at elevated temperatures as high as 65.5° C. (150° F.), preferably at a temperature about 48.9° C. (120° F.).
- the time required for full hydration and the viscosity of the dispersion are both considerably reduced when the dispersion is prepared at an elevated temperature, but coating dispersions prepared at ambient temperature only require an increase in hydration time and a slight reduction in solids content to perform completely satisfactorily.
- these formulations may be prepared on the day preceding the coating operation, if that is more convenient; however, a period of mixing will be required to overcome the thixotropic behavior of a formulation which sets up during overnight storage.
- constant stirring of the microcrystalline and propylene glycol alginate-based formulations of this invention does not need to be continued throughout the coating procedure, but mixing may continue, if preferred.
- Any commercial spray coater may be used to apply the coating.
- useful coaters are Vector High Coaters manufactured by Vector Corporation and Accela-Cota manufactured by Thomas Engineering.
- Equipment variables which one skilled in the art can manipulate to provide an elegant coating based on dry blends of microcrystalline cellulose and propylene glycol alginate, include inlet temperature, outlet temperature, air flow, speed of rotation of the coating pan, and the rate at which the coating formulation is pumped to the coater. It is important that the inlet and outlet temperatures be controlled so that they are high enough to efficiently dry the coating to prevent the tumbling action of the already-coated tablets from damaging the newly-applied coating before more coating is applied to the same tablets.
- Hydroxyethylcellulose binds water more effectively than propylene glycol alginate does.
- the presence of the major amount propylene glycol alginate in the formulations of this invention has a significant effect on the speed of drying of the edible coatings. Drying times are reduced considerably because of the presence of the propylene glycol alginate which dilutes the negative effect of HEC on drying time.
- the outlet temperature can be reduced and still provide short enough drying time to be commercially useful.
- Hydroxyethylcellulose is particularly susceptible to clogging spray nozzles at high temperatures.
- An additional benefit provided by the formulations of this invention is the avoidance of clogging of the spray nozzles with dispersions being sprayed at high temperatures.
- the level of coating applied to pharmaceutical or veterinary dosage forms is preferably between about 0.5% to about 4% by weight of the uncoated dosage form, more preferably about 2% to about 3.5%, by weight of the uncoated dosage form.
- This level of coating will provide an elegant, serviceable coating to a wide variety of dosage forms. To apply a heavier coating to tablets would not be economical, and it might adversely affect disintegration of the tablets or other properties. Too light a coating would not provide optimal properties normally expected from a coating, for example, improved friability or adequate taste masking.
- the coating level should be about 5% to about 10% by weight of the uncoated confection.
- Seed coatings should be in the range of about 3% to about 6% by weight of the uncoated seeds.
- Fertilizers and pesticide tablets and granules benefit from coating of 1% to about 3%, by weight of the uncoated granules or tablets.
- the coatings of the present invention may be applied successfully to tablets having a wide variety of active ingredients incorporated therein.
- active ingredients for example, it has been reported that multivitamin tablets are difficult to coat because of the lipophilic surface properties of the vitamins.
- ibuprofen is a challenging active ingredient to coat. Tablets comprising both of these difficult-to-coat active ingredients have been coated readily with the instant invention, providing elegant tablets. Additionally, the coatings have been applied to tablets which have been debossed with letters or a logo without bridging which would hide, or even obliterate, the debossed design.
- An additional utility of the coating formulations of this invention is as a replacement for sugar coating of tablets.
- a sugar coating is applied primarily to increase the weight and/or size of the tablet, but this is an old art which presents numerous problems. It is, therefore, desirable to replace the traditional sugar coating with a more easily applied coating.
- This coating procedure has the additional advantage that no topcoat is required to be applied as it is done with a sugar coating.
- All components of the formulation are typically pharmaceutically acceptable, edible food grade materials.
- a Vector High Coater LDCS was charged with 1 Kg of each of acetaminophen tablets and ibuprofen caplets.
- the coater was operated at an inlet temperature of 84-85° C., an outlet temperature of 40-45° C., and 14-15 rpm.
- a 3 weight percent coating based on the weight of the tablets & caplets was applied. Friability of the tablets and caplets was 0% after 10 minutes.
- Example 1 By the method of Example 1, the dry components of each formulation were dry blended and dispersed in deionized water after which the triacetin and liquid components were added to the dispersion. The dispersion was then sprayed on caplets which were tested for friability.
- Example 2 By the method of Example 1, the dry components of each formulation were dry blended then dispersed in deionized water. The dispersion was then hydrated and sprayed on caplets which were tested for friability, gloss and disintegration time. The examples are summarized in Table 3 below.
Abstract
An edible, hardenable coating composition is disclosed containing microcrystalline cellulose, a film forming amount of propylene glycol alginate, and a strengthening polymer, optionally in combination with at least one of a plasticizer, a surfactant, or a filler. The coating composition of the present invention may be applied to pharmaceutical and veterinary solid dosage forms, confectionery, seeds, animal feed, fertilizers, pesticide tablets, and foods and provides an elegant prompt release coating which-does not retard the release of active ingredients from the coated substrate.
Description
- This application claims the benefit of prior Provisional Application Nos. 60/162,514, filed Oct. 29, 1999, 60/167,407, filed Nov. 24, 1999, 60/172,526, filed Dec. 17, 1999, 60/189,588, filed Mar. 15, 2000, and 60/217,499, filed Jul. 11, 2000.
- This invention relates to edible, hardenable coating compositions comprising microcrystalline cellulose (MCC), a film forming amount of propylene glycol alginate (PGA) and a strengthening polymer, optionally containing a plasticizer, a surface active agent, a filler, a coloring agent or a combination of such optional ingredients. The coatings of the present invention can be applied to pharmaceutical, including neutraceutical, and veterinary solid dosage forms, such solid substrates such as seeds, animal feed, fertilizers, pesticide tablets and granules, and also to confectionery and foods. They are readily dispersed in aqueous media, and, when applied as a coating, provide high lustre coatings, which do not retard or extend release of active ingredient from a coated substrate.
- It is a common practice to coat pharmaceutical and veterinary tablets to obtain several advantages. Among these are to improve the surface characteristics of tablets to make them easier to swallow, to reduce the absorption of water or moisture which can potentially degrade the active ingredient or promote some other undesirable change in the tablet structure, and simply to make a more elegant appearing tablet.
- Another very important function of a pharmaceutical or veterinary tablet coating is to improve the integrity of the tablet itself. Uncoated tablets are often subject to being abraded or chipped, causing a loss of active ingredient in the process. More dramatically, they may break into two or more pieces. One measure of a useful coating is its ability to prevent any of these physical degradations of tablet structure. The effectiveness of a coating material to prevent abrading, chipping, or breakage of the tablet is determined by friability testing.
- Confectionery and foods may be coated with a formulation to preserve the confection or food from deteriorating by contact with the oxygen and the moisture in the atmosphere. Coatings also can provide improved appearance and desirable organoleptic properties to the food as well as preventing loss of flavor.
- Seeds may be coated to preserve the viability of the seeds by protecting against moisture. They may also be coated as a means for increasing particle size to facilitate mechanical planting. A dye can be included in the coating formulation to identify the seeds as to quality, type, or some other designation. Frequently, a pesticide, e.g., a fungicide, is incorporated into the coating formulation to protect both the seed itself and the seedling that results from germination of the seed. In all cases, this coating must not decrease the viability of the seeds or interfere with germination when the seeds are planted in the soil.
- Animal feed may be coated to improve its flowability, appearance and its resistance to powdering or dusting. In such applications, the coating may be formulated to include vitamins, hormones, antibiotics, or the like, to benefit the livestock which will consume the feed.
- Fertilizers, in either granular or tableted forms, may be coated to retain the integrity of the form and, especially, to protect the fertilizer from moisture which can cause agglomeration during storage, which could make rapid, even application to the soil difficult or inconvenient.
- Coating of tableted pesticide formulations serves to maintain the integrity of the tablets or granules until they are placed in water where they rapidly disintegrate, forming a solution or slurry to be applied to the soil or plants. A second, and equally important, function of the coatings on tablets containing pesticides is to prevent human contact with the pesticide, thereby increasing safety for those handling and applying the pesticide.
- In the preparation of a coating formulation to be sprayed, the film-former is usually dissolved or dispersed in a solvent, for example, water, along with the other ingredients of the formulation. In aqueous systems, since many polymers require significant time to become fully hydrated, the coating formulation must frequently be prepared in advance of the time it is to be applied to the tablets. A common procedure is to prepare these coating formulations the day preceding the coating operation in order to assure adequate hydration of the polymers used in them.
- A particular disadvantage of coatings based primarily on hydroxypropylmethylcellulose (HPMC) is that the coating may harden over time and therefore increase tablet disintegration times. An increase in disintegration time delays the bioavailability of the active ingredient at least in proportion to the increase in disintegration time. Many other agents commonly used in coating compositions are also known to delay release of pharmaceutical agents, such as enteric coatings which use polymeric film forming materials which are insoluble in water, or gastric fluid, some of these being specifically selected to by-pass both the stomach and small intestine and provide colonic release.
- The coatings of this invention meet U.S. Pharmacopeia standards for rapid or immediate dissolution (U.S.P. monograph 23) of active ingredients from tablets or other solid dosage forms coated with them. They provide prompt release or dissolution consistent with the release rates which is normally obtained with the uncoated tablets or other substrates. Thus, they do not adversely impact or retard release of active ingredients from a substrate coated with them. Further, the coatings of this invention are readily dispersed and rapidly hydrated in aqueous media for application to a coating substrate, and provide elegant coatings which have all the benefits of coatings now in commercial use without the drawbacks that are common to them.
- It has been found that these and other advantages may be achieved in accordance with the present invention by a coating composition which comprises a unique combination of materials specifically adapted for prompt release when placed in aqueous media or ingested. The coating composition of the present invention comprises microcrystalline cellulose, a film forming amount of propylene glycol alginate and a strengthening polymer, and may additionally contain a plasticizer, a surface active agent, a filler, a coloring agent or combination of these additional ingredients. More specifically, the present invention provides a prompt release, edible, hardenable coating composition, as well as dry coatings and aqueous dispersions thereof and solid dosage forms coated therewith.
- For purposes of this application, the term “edible” is intended to mean food grade materials which are approved by regulatory authorities for use in pharmaceutical or food applications. The term “hardenable,” used to describe the coating compositions of this invention, is intended to include only those coating compositions that are capable of being dried from an aqueous solution or dispersion thereof into a solid coating which resists abrasive forces, i.e. a hardened coating, as distinguished from those “enrobing” coatings on confections which set up into a soft coating that can be handled and packaged but which do not resist abrasive forces significantly. The terms “immediate,” “rapid,” or “prompt,” as applied to dissolution rates or times for the coating compositions of this invention or tablets coated with the compositions of this invention, mean that the coatings of this invention meet U.S. Pharmacopeia standards (U.S.P. monograph 23) for rapid or immediate dissolution of active ingredients from tablets or other solid dosage forms coated with them. Thus, they provide prompt release or dissolution consistent with the release rates which is normally obtained with the uncoated tablets or other substrate. They do not, when placed in water or ingested, adversely impact or retard release or dissolution of tablets or other dosage forms coated with them. Coatings made in accordance with the present invention are substantially or completely disintegrated and/or dissolved within less than 10 minutes after being ingested or placed in aqueous media. These definitions are intended to apply throughout this application unless a contrary meaning is clearly indicated.
- The microcrystalline cellulose, simply blended with propylene glycol alginate, provides important film characteristics required to provide an elegant coating which is particularly useful in, for example, coating pharmaceutical and veterinary tablets, caplets, granules, and spheres which contain active ingredients which require release promptly after being placed in aqueous media or ingested.
- Microcrystalline cellulose is a purified, partially depolymerized cellulose that is generally produced by treating a source of cellulose, preferably alpha cellulose in the form of a pulp from fibrous plants, with a mineral acid, preferably hydrochloric acid. The acid selectively attacks the less ordered regions of the cellulose polymer chain, thereby exposing and freeing the crystallite sites, forming the crystallite aggregates which constitute microcrystalline cellulose. These are then separated from the reaction mixture and washed to remove degraded by-products. The resulting wet mass, generally containing 40 to 60
- For purposes of this invention, a film forming amount of propylene glycol alginate may be in the range of about 10% to about 50%, more specifically about 12% to about 50%, by dry weight of the coating composition. The propylene glycol alginate employed in the present invention may vary widely in viscosity. A typical high viscosity propylene glycol alginate is such that a 2% aqueous solution thereof has a viscosity in the range of 700 to 1800 mPa·s at 25° C., and is commercially available as Protonalg ester SD-LB, Pronova/FMC Corporation. A typical low viscosity propylene glycol alginate is such that a 2% aqueous solution thereof has a viscosity in the range of 20-30 mPs·s at 25° C., and is commercially available as Profoam®, Pronova/FMC Corporation.
- High viscosity propylene glycol alginate is generally employed in a lower amount than that employed for low viscosity material, typically in the range of 10% to about 20% by dry weight of the coating composition, as illustrated in examples 1-6 below. Use of substantially higher amounts of high viscosity propylene glycol alginate may result in coating solutions which are too viscous, tend to plug coating equipment, and may not flow sufficiently to form a satisfactory coating. Low viscosity propylene glycol alginate conversely is generally used in a higher amount, typically in the range of 20% to 50% by dry weight of the coating composition, as illustrated in examples 7 through 30.
- Propylene glycol alginate may be used in combination with other film forming materials, for example, carrageenan and cellulosic polymers such as HPMC and hydroxypropylcellulose.
- Carrageenan, preferably iota carrageenan, may suitably be employed as a multifunctional component in combination with propylene glycol alginate at a concentration in the range of about 3% to about 20% of the dry weight of the coating composition. When carrageenan is employed in the composition at a concentration in the range of about 3% to about 8%, it is believed to serve primarily to improve the gloss of the resulting coating, that is, as a gloss enhancer. When used for this purpose the weight ratio of propylene glycol alginate to carrageenan is suitably in the range of about 2:1 to about 10:1.
- Carrageenan may also be used at a level above about 9%, for example, at a concentration in the range of about 9% to about 20%, more specifically in the range of 10% to about 15%. At these levels it is believed to serve not only to improve gloss of the coating, but also to contribute film forming properties and to contribute to the strength and integrity of the resulting film coating. Depending on the weight ratio of propylene glycol alginate to carrageenan, carrageenan may be viewed to function as a co-film-former or as a supplemental or secondary film-former in the coating compositions. Such a weight ratio of propylene glycol alginate to carrageenan may be in the range of 2:1 to about 0.8:1. For example, when the weight ratio of propylene glycol alginate to carrageenan is in the range of about 1.5:1 to about 2:1, propylene glycol alginate may be considered to be the primary film-former and carrageenan the secondary film-former, as illustrated in examples 18 through 21 and 25 through 30. When approximately equal amounts of propylene glycol alginate and carrageenan are employed, that is, when the propylene glycol alginate to carrageenan weight ratio is, for example, in the range of about 1:0.8 to about 1:1.2, each of them may be considered to contribute relatively equal film forming properties to the resulting film coating, thus are considered to be co-film-formers as illustrated by examples 18 and 20-24.
- The weight ratio of microcrystalline cellulose to propylene glycol alginate in the compositions of this invention may vary depending on the application, but generally range from about 90:10 to about 20:80, more specifically from about 80:20 to about 20:80. A particular advantage for the dry, physical blends is that the ratio can be easily changed by simple blending techniques rather than manufacturing different ratios of a coprocessed material. Thus, the dry, physical blends provide great flexibility for specific applications having different requirements.
- A dry, physical blend of microcrystalline cellulose and a film forming amount of propylene glycol alginate, a strengthening polymer, preferably, hydroxyethylcellulose (HEC), are present in the coating formulation of this invention, advantageously in combination with other optional ingredients such as a plasticizer, a surfactant, a filler or a coloring agent, other conventional excipients or combinations thereof. Other strengthening polymers which can provide the same benefit and may be used instead of HEC include HPMC, hydroxypropylcellulose, ethylcellulose, methylcellulose and polyvinylpyrrolidone (PVP), however care must be exercised in the use of such alternative materials to avoid retarding release of active ingredients and/or bioavailability.
- The preferred amount of strengthening polymer is less than the total amount of microcrystalline cellulose and propylene glycol alginate present in the composition. Depending on the desired hardness of the coating, the strengthening polymer may be employed in the composition at a level of about 0.5% to about 30%, advantageously about 5% to 30% to provide strength and improved appearance to the coating. This strength can be demonstrated by casting films of coating formulations on a flat, non-adherent surface, cutting strips of uniform width from the casting, and subjecting the strips to tensile testing on, for example, an Instron Tensile Tester. The results of these tests show a very significant increase in tensile strength and decreased brittleness of the film when HEC or another strengthening polymer is included in the formulation. Strengthening polymers suitable for use in this invention, which will not retard release from tablets or other solid dosage forms, are those polymers having a viscosity equal to or less than 20 mPa·s in a 2% aqueous solution at 20° C. When a strengthening polymer is employed in the composition in absence of a plasticizer, it is generally employed at about 15% to about 30% by dry weight coating composition, and HEC is preferably employed at about 20% to about 25% by dry weight of the formulation.
- In addition to the foregoing ingredients, the compositions of this invention may also contain at least one of a plasticizer, a surfactant, a filler, a coloring agent or a combination of these additional components of the composition. Thus, a conventional plasticizer may also be included in the coating composition. Suitable plasticizers include polyethylene glycol, triacetin, dibutyl sebacate, propylene glycol, sorbitol, glycerin, and triethyl citrate. Of these, triacetin is preferred. These plasticizers may be employed in the coating compositions of the invention at about 18% to about 36% by dry weight of the coating composition, advantageously about 20% to about 30% by dry weight of the coating composition.
- Fillers suitable for use in the compositions of the invention include, for example, calcium carbonate, dicalcium phosphate and carbohydrates, such as starch, maltodextrin, lactose, mannitol and other sugars or croscarmellose sodium. Of these, mannitol or maltodextrin is a preferred filler. Surfactants which are either anionic or nonionic may be used beneficially in the edible, hardenable coating compositions of the present invention. Useful surfactants may be, for example, sodium lauryl sulfate, hydroxylated soy lecithin, polysorbates, and block copolymers of propylene oxide and ethylene oxide. Coloring agents and opacifiers which may be used in these coatings or added to a suspension thereof include aluminum lakes, insoluble pigments, water soluble dyes, titanium dioxide, and talc. Stearic acid or a salt or ester thereof, may be included at a level of about 1% to about 5% by dry weight of the compositions to increase gloss of the coating, particularly when a plasticizer is not employed in the composition.
- A coating formulation of this invention may be sold as a dry powder formulation or as a ready-to-use dispersion in water. For aqueous dispersions it is preferred that these be prepared under aseptic conditions. Heating the water to an elevated temperature, for example, 85° C., prior to preparation of the dispersion has shown that bacteria, mold, and yeast growth are prevented for at least 48 hours on agar pour plates. Therefore, if the containers for the dispersion are properly sanitized and then kept closed after being filled until the dispersion is used, there is little likelihood of bacteria, mold, or yeast growing in the dispersion. Alternatively, if a formulation is to be sold as an aqueous dispersion to be stored for a period of time, a preservative may be added. A combination of methyl and/or propyl paraben has been found to be useful in this regard.
- On a dry weight percentage basis the composition of this invention comprises from about 15% to about 50% of microcrystalline cellulose, about 10% to about 50% by weight of propylene glycol alginate, and about 5% to about 25% of strengthening polymer. If a plasticizer is employed, it is advantageously used at about 20% to about 30% by weight of the composition. The composition of the invention may also include an inert filler at about 2% to about 28% by weight. Optionally, about 1% to about 30% by weight of the formulation may comprise edible coloring agents and opacificiers such as talc or titanium dioxide, including from 1% to about 8% of coloring component such as a food dye or pigment, preferably about 1% to about 3%. Other optional ingredients may include a surfactant at about 0.5% to about 10%, advantageously 0.5 to about 7%, preferably 1.25% to 3% when a filler such as mannitol is present. When no filler is employed higher amounts of surfactants such as lecithin may be employed at a level of about 3% to about 20%. Preservatives, such as methyl paraben at 0.75% to 1.50% and/or propyl paraben at 0.075% to 0.15% may also be present in the formulation.
- The low level of fillers present in these coating formulations, particularly when the opacifier is titanium dioxide, enables the formulator to utilize relatively small amounts of coloring agent. Since coloring agents are quite costly, this provides a significant cost reduction from those formulation requiring from 6% to about 16% to effectively color prior art coating formulations.
- The viscosity of the hydrated formulation can be important. It ideally should be low enough to be pumped to a spray unit continuously and then sprayed evenly in a useful pattern onto the substrate being coated. A useful concentration of the dry ingredients in water on a weight percentage basis, therefore, may be about 6% to about 15%, advantageously 6.5% to 11%, preferably about 8% to about 11%. To assure uniformity of the coating composition, it may be preferable to maintain agitation of the aqueous dispersion during the entire period of its being sprayed onto the pharmaceutical or veterinary solid dosage forms, confectionery, seeds, animal feed, fertilizer, pesticide tablets, or food.
- The preferred edible, hardenable, prompt release coating formulations of this invention may generally be prepared and used according to a simple procedure. A dry blend of microcrystalline cellulose and propylene glycol alginate, and a strengthening polymer, such as hydroxyethylcellulose, and optionally at least one additional ingredient, such as polyethylene glycol or other acceptable plasticizer, optionally together with a solid filler such as maltodextrin, lactose, mannitol or the like, preservatives, and/or surfactants are blended to form dry coating composition. Addition of edible coloring agents, for example, a water soluble dye or a pigment, may precede the hydration step required to prepare the final coating formulation. This dry mixture is then added slowly to the vortex of stirred, purified water. Stirring of this mixture is continued for a sufficient period to allow all of the components to be fully hydrated. If a colored coating material is required a water soluble dye or a pigment may also be added, preferably as a dispersion or solution, to the hydrated coating composition. Optionally surfactants, and/or plasticizers may also be added at this stage of the process.
- In the formulations of microcrystalline cellulose and propylene glycol alginate, a simple propeller mixer provides adequate agitation for rapid hydration. The period of hydration may be as short as 0.5 hours. It may, and preferably should, be longer, but more than 3 hours is not believed to be necessary. Hydration can take place at room temperature or at elevated temperatures as high as 65.5° C. (150° F.), preferably at a temperature about 48.9° C. (120° F.). The time required for full hydration and the viscosity of the dispersion are both considerably reduced when the dispersion is prepared at an elevated temperature, but coating dispersions prepared at ambient temperature only require an increase in hydration time and a slight reduction in solids content to perform completely satisfactorily. As previously stated, these formulations may be prepared on the day preceding the coating operation, if that is more convenient; however, a period of mixing will be required to overcome the thixotropic behavior of a formulation which sets up during overnight storage. Unlike coating formulations based primarily on hydroxyalkyl ethers of cellulose, for example, HPMC, constant stirring of the microcrystalline and propylene glycol alginate-based formulations of this invention does not need to be continued throughout the coating procedure, but mixing may continue, if preferred.
- Any commercial spray coater may be used to apply the coating. Examples of useful coaters are Vector High Coaters manufactured by Vector Corporation and Accela-Cota manufactured by Thomas Engineering. Equipment variables which one skilled in the art can manipulate to provide an elegant coating based on dry blends of microcrystalline cellulose and propylene glycol alginate, include inlet temperature, outlet temperature, air flow, speed of rotation of the coating pan, and the rate at which the coating formulation is pumped to the coater. It is important that the inlet and outlet temperatures be controlled so that they are high enough to efficiently dry the coating to prevent the tumbling action of the already-coated tablets from damaging the newly-applied coating before more coating is applied to the same tablets.
- Hydroxyethylcellulose binds water more effectively than propylene glycol alginate does. Thus, the presence of the major amount propylene glycol alginate in the formulations of this invention has a significant effect on the speed of drying of the edible coatings. Drying times are reduced considerably because of the presence of the propylene glycol alginate which dilutes the negative effect of HEC on drying time. Thus, in the case of low melting active pharmaceutical agents, for example, ibuprofen, the outlet temperature can be reduced and still provide short enough drying time to be commercially useful.
- Hydroxyethylcellulose is particularly susceptible to clogging spray nozzles at high temperatures. An additional benefit provided by the formulations of this invention is the avoidance of clogging of the spray nozzles with dispersions being sprayed at high temperatures.
- The level of coating applied to pharmaceutical or veterinary dosage forms is preferably between about 0.5% to about 4% by weight of the uncoated dosage form, more preferably about 2% to about 3.5%, by weight of the uncoated dosage form. This level of coating will provide an elegant, serviceable coating to a wide variety of dosage forms. To apply a heavier coating to tablets would not be economical, and it might adversely affect disintegration of the tablets or other properties. Too light a coating would not provide optimal properties normally expected from a coating, for example, improved friability or adequate taste masking.
- For confections the coating level should be about 5% to about 10% by weight of the uncoated confection. Seed coatings should be in the range of about 3% to about 6% by weight of the uncoated seeds. Fertilizers and pesticide tablets and granules benefit from coating of 1% to about 3%, by weight of the uncoated granules or tablets.
- From the following examples is has been shown that the coatings of the present invention may be applied successfully to tablets having a wide variety of active ingredients incorporated therein. For example, it has been reported that multivitamin tablets are difficult to coat because of the lipophilic surface properties of the vitamins. Similarly, ibuprofen is a challenging active ingredient to coat. Tablets comprising both of these difficult-to-coat active ingredients have been coated readily with the instant invention, providing elegant tablets. Additionally, the coatings have been applied to tablets which have been debossed with letters or a logo without bridging which would hide, or even obliterate, the debossed design.
- An additional utility of the coating formulations of this invention is as a replacement for sugar coating of tablets. A sugar coating is applied primarily to increase the weight and/or size of the tablet, but this is an old art which presents numerous problems. It is, therefore, desirable to replace the traditional sugar coating with a more easily applied coating. This coating procedure has the additional advantage that no topcoat is required to be applied as it is done with a sugar coating.
- Storage of coated tablets under ambient temperature and humidity and 40° C. and 75% relative humidity for one to three months has demonstrated that no significant degradation has occurred. These tablets have disintegrated within the same length of time as the same batch of newly coated tablets did, and in each case provided dissolution rates and times substantially equal to those of the uncoated tablets used as a substrate for coating. This is an additional unexpected benefit of the coatings based on propylene glycol alginate and microcrystalline cellulose, and it differs from the known drawbacks of coating formulations in which HPMC is the primary or only film-former.
- All components of the formulation are typically pharmaceutically acceptable, edible food grade materials.
- The following examples, in which percentages are weight percent and tablet hardness is in Kiloponds (Kp), are provided to demonstrate the method of preparation and application of these elegant coatings, but they are not intended to be limiting as to amounts and the type of optional ingredients or the specific method of application of the tablet coating described herein.
- In a Patterson-Kelly twin shell blender were placed 48.0 grams of a blend of microcrystalline cellulose (Avicel® PH-105, 35 grams) and propylene glycol alginate (13 grams), 20 grams of hydroxyethylcellulose (Aqualon®250L), 25 grams of triacetin, and 3 grams of Pluronic F-68 (BASF). After the dry components had been thoroughly blended, the blend was added slowly to the vortex of 1011.1 grams deionized water which was stirred with a Lightnin' mixer. The suspension was stirred for 2 hours at ambient temperature to fully hydrate the composition. To this dispersion was added 4.0 grams of red #40 liquid dispersion (Crompton and Knowles). A Vector High Coater LDCS was charged with 1 Kg of each of acetaminophen tablets and ibuprofen caplets. The coater was operated at an inlet temperature of 84-85° C., an outlet temperature of 40-45° C., and 14-15 rpm. During the spraying, which required 56 minutes, a 3 weight percent coating, based on the weight of the tablets & caplets was applied. Friability of the tablets and caplets was 0% after 10 minutes.
- By the method of Example 1, the dry components of each formulation were dry blended and dispersed in deionized water after which the triacetin and liquid components were added to the dispersion. The dispersion was then sprayed on caplets which were tested for friability. These examples are summarized in Table 1 below:
TABLE 1 Example: 2 3 4 5 Ingredients Weight (grams) Avicel PH-105 37 35 37 37 Hydroxyethyl- 22 20 22 22 cellulose PGAa 13 13 12 12 Pluronic F-68 3.5 3 — 1.5 Red #40 24.5 4 6 7.5 dispersion Triacetin — 25 — — Mannitolb — — 18 15 Iota — — 5 5 carrageenan Deionized 1011.1 1011.1 1011.1 1011.1 water Hydration time 2 hours >1 hour 6 hours >1 hour Caplets Charge (Kg) Acetaminophen 0.67 1 0.67 0.67 Ibuprofen 0.67 1 0.67 0.67 Chlor- 0.67 — 0.67 0.67 pheniramine Spray conditions Inlet 84-89° C. 83-85° C. 63-69° C. 69-74° C. temperature Outlet 36-40° C. 40-42° C. 38-39° C. 30-32° C. temperature Drum speed 14-15 rpm 15 rpm 11 rpm 10 rpm Time 54 minutes 57 minutes 55 minutes 58 minutes Coating 3 3 3 3 weight (%) Friability (10 minutes) Acetaminophen 0% 0% 0% NT Ibuprofen 0% 0% slight NT Chlor- NTc — NT NT pheniramine - The components of this example were dry blended. The dry blend was dispersed in deionized water, then sprayed on caplets and/or tablets which were tested for friability. This example is summarized in Table 2:
TABLE 2 Example: 6 Ingredients Weight (grams) Avicel PH-105 37 PGAa 13 Iota carrageenan 5 Hydroxyethylcellulose 22 Mannitolb 17.5 Pluronic F-68 3.5 Blue Lake #2 2 Deionized water 1150 Hydration time 2 hours Caplets Charge (Kg Ibuprofen 1 Chlorpheniramine 1 Spray conditions Inlet temperature 97-99° C. Outlet temperature 31-35° C. Drum speed 12-13 rpm Time 62 minutes Coating weight % 3% Friability (10 minutes) Ibuprofen 0% Chlorpheniramine 0% - By the method of Example 1, the dry components of each formulation were dry blended then dispersed in deionized water. The dispersion was then hydrated and sprayed on caplets which were tested for friability, gloss and disintegration time. The examples are summarized in Table 3 below.
- These additional examples were also prepared and applied in the manner of Examples 7-14. The resulting coating compositions are set forth in Table 4 below.
TABLE 3 Example 7 8 9 10 11 12 13 Ingredients Percentage by weight Avicel PH105 20 20 15 20 25 20 25 PGAa 30 40 50 40 30 30 35 HEC 20 10 5 — — 15 15 Lecithinb 3 3 3 — 3 3 3 Maltodextrin M180 17 17 17 25 22 17 17 Iota Carrageenan 5 5 5 5 5 5 5 Red hydrophilic Iron Oxide 5 5 5 — 15 10 — Blue lake/Yellow lake blend — — — 10 — — — % Solids 8 8 8 8 8 8 9 Caplets Charged (Kg) Acetominophen 2 2 12 12 12 12 12 Inlet Temperature (° C.) 78-88 67-90 46-53 50-53 52-54 52-54 67-72 Exhaust Temperature (° C.) 35-41 29-36 33-36 32-38 32-36 34-36 30-35 RPM 13 15 9 9 9 8 13 Spray Rate (gm/ml) 12 19 55 66 72 67 11 Time (minutes) 70 41 84 85 64 66 59 Coating weight (%) 3 3 3 3 3 3 3 Appearance (shine)d 5 4 4 2 3 4 4 Friability (% - 10 minutes) 0 0 0 MCc MCc 0 0 Disintegration Time, 37 ° C. (minutes) <5 <5 <5 <12 <5 <5 <5 -
TABLE 4 Example: 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Ingredients (%) By Weight Avicel PH-105 25 20 25 20 34 25 20 20 25 25 25 25 25 22 25 25 25 PGAa 35 35 35 30 13 26 25 25 13 13 13 20 18 26 20 15 20 Hydroxyethylcellulose 15 15 17 20 22 22 20 20 20 20 20 17 15 20 15 20 20 Iota carrageenan 5 5 5 5 12 12 12 12 15 15 15 12 12 12 12 10 10 Lecithinb 3 3 5 3 7 3 3 3 7 7 5 7 3 7 3 5 Maltodextrin 3 3 3 3 3 3 3 3 3 3 3 3 3 3 PIGMENT (Var) 5 10 10 5 5 7 10 10 5 7 7 7 5 8 8 10 10 Mannitolc 9 9 — 17 4 2 7 10 10 6 10 3 — — — Lactose 15 Croscarmellose 5 3 5 3 5 3 2 Calcium carbonate 7 7 — dicalcium Phosphate 5 11 5 PVP 29/32, 25, s603
Claims (19)
1. An edible, hardenable, prompt release coating composition comprising (a) microcrystalline cellulose, (b) a film forming amount of propylene glycol alginate, (c) a strengthening polymer and optionally (d) at least one of a plasticizer, a surface active agent and a filler.
2. The coating composition of claim 1 , comprising 5% to 50% by weight microcrystalline cellulose, 10% to 50% by weight propylene glycol alginate, and 5% to 25% by weight strengthening polymer.
3. The coating composition of claim 2 , comprising 12% to 50% by weight propylene glycol alginate.
4. The coating composition of claim 1 in which the strengthening polymer is hydroxyethylcellulose.
5. The coating composition of claim 4 , further comprising from 20% to 30% by weight plasticizer.
6. The coating composition of claim 5 , in which the plasticizer is triacetin.
7. The coating composition of claim 4 , further comprising from 1% to 5% by weight surface active agent.
8. The coating composition of claim 4 , further comprising from 10% to 30% by weight of a filler.
9. The coating composition of claim 8 , in which the filler is at least one of mannitol or maltodextrin.
10. The coating composition of claim 1 , in which the weight ratio of microcrystalline cellulose to propylene glycol alginate is in the range of 90:10 to 20:80.
11. The coating composition of claim 1 , wherein the microcrystalline cellulose has an average particle size in the range of 1 to 50 microns.
12. The coating composition of claim 10 , further comprising carrageenan in an amount of from 3% to 20% by dry weight of the composition.
13. The coating composition of claim 12 , wherein carrageenan is present in an amount in the range of 3% to 8% by dry weight of the composition and the weight ratio of propylene glycol alginate to carrageenan is in the range of 2:1 to 10:1
14. The composition of claim 12 wherein carrageenan is present in an amount in the range of 9% to 20% by dry weight of the composition and the weight ratio of propylene glycol alginate to carrageenan is in the range of 2:1 to 0.8:1.
15. The coating composition of claim 1 , wherein said composition is a dry blend.
16. The coating composition of claim 1 , wherein said composition is an aqueous dispersion.
17. The coating composition of claim 1 further comprising a coloring agent.
18. A solid dosage form coated with the composition of claim 1 .
19. A method for forming an edible, hardenable, prompt release coating composition comprising
i) combining (a) microcrystalline cellulose, (b) a film forming amount of propylene glycol alginate, (c) a strengthening polymer and optionally (d) at least one of a plasticizer, a surface active agent and a filler; and
ii) forming a film coating by spraying an aqueous suspension of i) onto a substrate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/306,649 US20030129238A1 (en) | 1999-10-29 | 2002-11-27 | Edible MCC/PGA coating composition |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16251499P | 1999-10-29 | 1999-10-29 | |
US16740799P | 1999-11-24 | 1999-11-24 | |
US17252699P | 1999-12-17 | 1999-12-17 | |
US18958800P | 2000-03-15 | 2000-03-15 | |
US21749900P | 2000-07-11 | 2000-07-11 | |
US09/696,780 US6500462B1 (en) | 1999-10-29 | 2000-10-26 | Edible MCC/PGA coating composition |
US10/306,649 US20030129238A1 (en) | 1999-10-29 | 2002-11-27 | Edible MCC/PGA coating composition |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/696,780 Continuation US6500462B1 (en) | 1999-10-29 | 2000-10-26 | Edible MCC/PGA coating composition |
Publications (1)
Publication Number | Publication Date |
---|---|
US20030129238A1 true US20030129238A1 (en) | 2003-07-10 |
Family
ID=27558517
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/696,780 Expired - Fee Related US6500462B1 (en) | 1999-10-29 | 2000-10-26 | Edible MCC/PGA coating composition |
US10/306,649 Abandoned US20030129238A1 (en) | 1999-10-29 | 2002-11-27 | Edible MCC/PGA coating composition |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/696,780 Expired - Fee Related US6500462B1 (en) | 1999-10-29 | 2000-10-26 | Edible MCC/PGA coating composition |
Country Status (9)
Country | Link |
---|---|
US (2) | US6500462B1 (en) |
EP (1) | EP1223920A1 (en) |
JP (1) | JP2003514778A (en) |
CN (1) | CN1198600C (en) |
AU (1) | AU1443401A (en) |
BR (1) | BR0014965A (en) |
IL (1) | IL149149A0 (en) |
TR (1) | TR200201111T2 (en) |
WO (1) | WO2001032152A1 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070026063A1 (en) * | 2005-07-29 | 2007-02-01 | Shin-Etsu Chemical Co., Ltd. | Composition for coating comprising low-substituted cellulose ether and coated preparation having unpleasant taste masked |
US20070128333A1 (en) * | 2005-09-30 | 2007-06-07 | Tuason Domingo C | Stabilizers and Compositions and Products Comprising Same |
WO2007087188A2 (en) * | 2006-01-20 | 2007-08-02 | Merck & Co., Inc. | Taste-masked tablets and granules |
US20080213360A1 (en) * | 2006-10-27 | 2008-09-04 | Fmc Corporation | Dry granulation binders, products, and use thereof |
US8469036B2 (en) | 2003-11-07 | 2013-06-25 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
US8801847B2 (en) | 2002-05-14 | 2014-08-12 | Fmc Corporation | Microcrystalline cellulose compositions |
US8927609B2 (en) | 2011-12-09 | 2015-01-06 | Fmc Corporation | Co-attrited stabilizer composition |
US9055757B2 (en) | 2011-10-05 | 2015-06-16 | Fmc Corporation | Stabilizer composition of co-attrited microcrystalline cellulose and carboxymethylcellulose, method for making, and uses |
US9826763B2 (en) | 2011-10-05 | 2017-11-28 | Fmc Corporation | Stabilizer composition of microcrystalline cellulose and carboxymethylcellulose, method for making, and uses |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001032150A1 (en) * | 1999-10-29 | 2001-05-10 | Fmc Corporation | Edible coating composition |
US6932861B2 (en) * | 2000-11-28 | 2005-08-23 | Fmc Corporation | Edible PGA coating composition |
ES2204330B1 (en) * | 2002-10-09 | 2005-03-01 | La Morella Nuts, S.A. | DRIED FRUIT COVERED WITH AN EDIBLE COATING FILM AND ITS OBTAINING. |
JP2006524743A (en) * | 2003-04-14 | 2006-11-02 | エフ エム シー コーポレーション | Uniform thermoreversible alginate film and soft capsule made therefrom |
NZ545880A (en) * | 2003-09-18 | 2008-07-31 | Fmc Corp | A method for dispersing metal oxides |
GB2416473A (en) * | 2004-07-22 | 2006-02-01 | Mars Inc | A confectionery product coated with a polymer film and method of manufacture |
BRPI0515416A (en) * | 2004-09-23 | 2008-07-22 | Fmc Corp | composition, solid form, film, and method for coating a solid form |
US8088414B2 (en) | 2006-02-07 | 2012-01-03 | Fmc Corporation | Latex or pseudolatex compositions, coatings and coating processes |
US20080131467A1 (en) * | 2006-11-30 | 2008-06-05 | Dennis Nelson | Film-coated solid dosage form |
WO2008140853A2 (en) * | 2007-05-08 | 2008-11-20 | Dow Global Technologies Inc. | Water dispersible polymer compositions |
US20100160363A1 (en) * | 2008-12-19 | 2010-06-24 | Aaipharma Services Corp. | Extended-release pharmaceutical formulations |
US20100159001A1 (en) * | 2008-12-19 | 2010-06-24 | Cardinal John R | Extended-Release Pharmaceutical Formulations |
EP3038602A4 (en) | 2013-08-28 | 2017-07-26 | Sensient Colors LLC | Edible coating compositions, edible coatings, and methods for making and using the same |
Citations (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2881085A (en) * | 1953-11-09 | 1959-04-07 | Abbott Lab | Thin film coating for tablets and the like |
US3251824A (en) * | 1961-08-22 | 1966-05-17 | Fmc Corp | Method of preparing stable aqueous dispersion-forming cellulosic aggregates |
US3297535A (en) * | 1963-02-28 | 1967-01-10 | Hoffmann La Roche | Shellac tablet coating compositions and methods of preparation |
US3438797A (en) * | 1965-10-21 | 1969-04-15 | Jerry Allen Biddle Sr | Method of preparing pharmaceutical tablets |
US3503769A (en) * | 1966-09-08 | 1970-03-31 | Alginate Ind Ltd | Method of modifying alkylene glycol alginates |
US3573058A (en) * | 1967-01-30 | 1971-03-30 | Swift & Co | Microcrystalline cellulose compositions co-dried with hydrocolloids |
US3576663A (en) * | 1967-05-29 | 1971-04-27 | Colorcon | Coated tablet |
US3649302A (en) * | 1969-11-10 | 1972-03-14 | Cpc International Inc | Process of producing a ready-to-spread frosting |
US3860733A (en) * | 1972-07-31 | 1975-01-14 | Merck & Co Inc | Microencapsulated product |
US3873694A (en) * | 1973-09-27 | 1975-03-25 | Cpc International Inc | Direct compression tabletting composition and pharmaceutical tablets produced therefrom |
US3883458A (en) * | 1973-02-02 | 1975-05-13 | Basf Ag | Flatting agents for coatings |
US3935326A (en) * | 1967-06-28 | 1976-01-27 | Boehringer Mannheim G.M.B.H. | Process for coating tablets with aqueous resin dispersions |
US3957966A (en) * | 1972-05-19 | 1976-05-18 | Gaf Corporation | Stabilized vitamin food coatings |
US4009131A (en) * | 1972-01-17 | 1977-02-22 | The Lubrizol Corporation | Powder coating compositions and metal objects coated therewith |
US4015999A (en) * | 1975-01-08 | 1977-04-05 | Ciba-Geigy Corporation | Pigment compositions |
US4143163A (en) * | 1976-06-30 | 1979-03-06 | Maxfibe, Inc. | Coated fibrous cellulose product and process |
US4250195A (en) * | 1979-09-24 | 1981-02-10 | Life Savers, Inc. | Method for applying soft flexible sugar coating to fresh chewing gum and coated chewing gum product |
US4252786A (en) * | 1979-11-16 | 1981-02-24 | E. R. Squibb & Sons, Inc. | Controlled release tablet |
US4257816A (en) * | 1979-09-17 | 1981-03-24 | Merck & Co., Inc. | Novel blend of algin, TKP, and guar gum |
US4263334A (en) * | 1978-05-31 | 1981-04-21 | Fmc Corporation | Water dispersible cellulosic powder and method of making the same |
US4311717A (en) * | 1980-05-19 | 1982-01-19 | Fmc Corporation | Stabilizing agent for dry mix food products |
US4316884A (en) * | 1979-01-25 | 1982-02-23 | Adria Laboratories, Inc. | Sustained release pharmaceutical formulation |
US4324554A (en) * | 1978-11-09 | 1982-04-13 | Merck & Co., Inc. | Use of TKP as an antimigrant |
US4330338A (en) * | 1978-10-02 | 1982-05-18 | Purdue Research Foundation | Pharmaceutical coating composition, and preparation and dosages so coated |
US4375468A (en) * | 1981-07-13 | 1983-03-01 | Verex Laboratories, Inc. | Constant order release aspirin composition and method of treating arthritis |
US4432966A (en) * | 1979-12-10 | 1984-02-21 | Roussel-Uclaf | Compressed tablets for disintegration in the colon comprising an active ingredient containing nucleus coated with a first layer containing microcrystalline cellulose which is coated with an enteric organic polymer coating |
US4505890A (en) * | 1983-06-30 | 1985-03-19 | E. R. Squibb & Sons, Inc. | Controlled release formulation and method |
US4513019A (en) * | 1983-07-06 | 1985-04-23 | Seppic | Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions |
US4576646A (en) * | 1983-07-06 | 1986-03-18 | Seppic | Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions |
US4636261A (en) * | 1984-10-24 | 1987-01-13 | Heinze Richard F | Dry lake system |
US4643894A (en) * | 1984-07-24 | 1987-02-17 | Colorcon, Inc. | Maltodextrin coating |
US4645662A (en) * | 1984-07-26 | 1987-02-24 | Lion Corporation | Oral composition |
US4652313A (en) * | 1984-10-24 | 1987-03-24 | Crompton And Knowles Corporation | Aqueous lake pigment suspension |
US4661162A (en) * | 1983-04-18 | 1987-04-28 | Sankyo Company, Limited | Enteric-soluble preparations |
US4666703A (en) * | 1984-03-23 | 1987-05-19 | Ciba-Geigy Corporation | Storage-stable, quick-disintegrating pressed shapes containing pharmaceutical active substances |
US4720378A (en) * | 1981-03-09 | 1988-01-19 | Imperial Chemical Industries Plc | Coated colored intagliated articles |
US4802924A (en) * | 1986-06-19 | 1989-02-07 | Colorcon, Inc. | Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products |
US4814181A (en) * | 1987-09-03 | 1989-03-21 | Alza Corporation | Dosage form comprising fast agent delivery followed by slow agent delivery |
US4816298A (en) * | 1987-11-27 | 1989-03-28 | The Dow Chemical Company | Method of making a granular, cold water dispersible coating composition |
US4828841A (en) * | 1984-07-24 | 1989-05-09 | Colorcon, Inc. | Maltodextrin coating |
US4892741A (en) * | 1987-06-24 | 1990-01-09 | Bayer Aktiengesellschaft | Press coated DHP tablets |
US4900557A (en) * | 1984-08-30 | 1990-02-13 | Troponwerke Gmbh & Co. Kg | Pellet formulation |
US4910028A (en) * | 1985-03-06 | 1990-03-20 | Griffith Laboratories U.S.A., Inc. | Honey coated and honey glazed roasted nuts and method for producing same |
US4913919A (en) * | 1986-11-18 | 1990-04-03 | Frito-Lay, Inc. | Coating composition for comestible products |
US4915954A (en) * | 1987-09-03 | 1990-04-10 | Alza Corporation | Dosage form for delivering a drug at two different rates |
US4981707A (en) * | 1987-03-24 | 1991-01-01 | Ogilvie Mills, Inc. | Dextrin-based food-grade adhesive including xanthan or carboxymethylcellulose or mixtures thereof |
US4981698A (en) * | 1986-12-23 | 1991-01-01 | Warner-Lambert Co. | Multiple encapsulated sweetener delivery system and method of preparation |
US4983399A (en) * | 1989-10-18 | 1991-01-08 | Eastman Kodak Company | Direct compression carrier composition |
US4994276A (en) * | 1988-09-19 | 1991-02-19 | Edward Mendell Co., Inc. | Directly compressible sustained release excipient |
US5006513A (en) * | 1987-11-09 | 1991-04-09 | Miles Inc. | Antimycotic compositions of nikkomycin compounds and azole antimycotica |
US5008113A (en) * | 1987-01-28 | 1991-04-16 | Shin-Etsu Chemical Co., Ltd. | Method for preparing film coated pharmaceutical preparations and method for improving properties thereof |
US5008117A (en) * | 1985-05-08 | 1991-04-16 | Eurand Italia S.P.A. | Formulation for preparing extemporaneous homogeneous microcapsule suspension |
US5009897A (en) * | 1988-06-24 | 1991-04-23 | Abbott Laboratories | Pharmaceutical granules and tablets made therefrom |
US5011701A (en) * | 1988-12-30 | 1991-04-30 | Kraft General Foods, Inc. | Low calorie food products having smooth, creamy, organoleptic characteristics |
US5082684A (en) * | 1990-02-05 | 1992-01-21 | Pfizer Inc. | Low-calorie fat substitute |
US5089270A (en) * | 1990-05-15 | 1992-02-18 | L. Perrigo Company | Capsule-shaped tablet |
US5098715A (en) * | 1990-12-20 | 1992-03-24 | Burroughs Wellcome Co. | Flavored film-coated tablet |
US5192569A (en) * | 1989-05-26 | 1993-03-09 | Fmc Corporation | Fat-like bulking agent for aqueous foods comprising microcrystalline cellulose and a galactomannan gum |
US5194464A (en) * | 1988-09-27 | 1993-03-16 | Takeda Chemical Industries, Ltd. | Enteric film and preparatoin thereof |
US5202129A (en) * | 1989-08-04 | 1993-04-13 | Tanabe Seiyaku Co., Ltd. | Process for micronizing slightly-soluble drug |
US5202137A (en) * | 1990-06-29 | 1993-04-13 | Berwind Pharmaceutical Services, Inc. | Method of inhibiting fat and oil migration from an oily substrate of a food product into a coating layer of a food product |
US5209942A (en) * | 1991-11-27 | 1993-05-11 | Thomas J. Lipton, Co., Division Of Conopco, Inc. | Low fat/no fat salad dressing having mimetic functional properties fat and a process therefor |
US5213738A (en) * | 1990-05-15 | 1993-05-25 | L. Perrigo Company | Method for making a capsule-shaped tablet |
US5286502A (en) * | 1992-04-21 | 1994-02-15 | Wm. Wrigley Jr. Company | Use of edible film to prolong chewing gum shelf life |
US5286510A (en) * | 1992-10-07 | 1994-02-15 | Thomas J. Lipton Co., Division Of Conopco, Inc. | Fat mimetic containing salad dressing and process therefor |
US5288501A (en) * | 1991-07-04 | 1994-02-22 | Merz + Co. Gmbh & Co. | Mechanically-stable, readily-disintegratable tablets made of small preformed particles containing active ingredients |
US5306506A (en) * | 1990-07-11 | 1994-04-26 | Eurand International S.P.A. | Pharmaceutical composition for rapid suspension in water |
US5310572A (en) * | 1987-02-03 | 1994-05-10 | Dow Corning Corporation | Process for forming a coated active agent-containing article |
US5389129A (en) * | 1991-05-29 | 1995-02-14 | Berwind Pharmaceutical Services, Inc. | Wax polish composition |
US5393333A (en) * | 1990-03-27 | 1995-02-28 | Societe Anonyme Societe D'exploitation De Produits Pour Les Industries Chimiques S.E.P.P.I.C. | Film-forming product for coating solid forms, process for its manufacture and products coated with this film-forming product |
US5411746A (en) * | 1993-02-24 | 1995-05-02 | Warner-Jenkinson Company, Inc. | Dye compositions and methods for film coating tablets and the like |
US5480479A (en) * | 1990-12-20 | 1996-01-02 | Warner-Jenkinson Company, Inc. | Wet powder film-forming compositions |
US5512092A (en) * | 1994-04-15 | 1996-04-30 | Shin-Etsu Chemical Co., Ltd. | Method for preparing aqueous emulsion for coating solid pharmaceutical preparations |
US5514435A (en) * | 1993-03-10 | 1996-05-07 | New Oji Paper Co., Ltd. | Adhesive sheet |
US5591455A (en) * | 1990-12-20 | 1997-01-07 | Warner-Jenkinson Company, Inc. | Wet powder film-forming compositions |
US5595762A (en) * | 1992-11-30 | 1997-01-21 | Laboratoires Virbac | Stabilized pulverulent active agents, compositions containing them, process for obtaining them and their applications |
US5624612A (en) * | 1993-08-25 | 1997-04-29 | Fmc Corporation | Nonaggregating hydrocolloid microparticulates, intermediates therefor, and processes for their preparation |
US5629003A (en) * | 1990-06-07 | 1997-05-13 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Rapidly disintegrating sheet-like presentations of multiple dosage units |
US5630871A (en) * | 1991-01-17 | 1997-05-20 | Berwind Pharmaceutical Services, Inc. | Film coatings and film coating compositions based on cellulosic polymers and lactose |
US5709896A (en) * | 1996-06-18 | 1998-01-20 | Fmc Corporation | Reduced-fat food dispersions and method of preparing |
US5733575A (en) * | 1994-10-07 | 1998-03-31 | Bpsi Holdings, Inc. | Enteric film coating compositions, method of coating therewith, and coated forms |
US5741600A (en) * | 1988-12-29 | 1998-04-21 | Deknatel Technology Corporation, Inc. | Absorbable coating and blend |
US5756123A (en) * | 1994-12-01 | 1998-05-26 | Japan Elanco Co., Ltd. | Capsule shell |
US5876739A (en) * | 1996-06-13 | 1999-03-02 | Novartis Ag | Insecticidal seed coating |
US5882707A (en) * | 1996-01-05 | 1999-03-16 | Bpsi Holdings, Inc. | Method of coating an edible substrate with sugar/syrup or sugarless solutions containing dry color concentrate |
US5885617A (en) * | 1994-07-12 | 1999-03-23 | Bpsi Holdings, Inc. | Moisture barrier film coating composition, method, and coated form |
US6030641A (en) * | 1997-06-03 | 2000-02-29 | Uni Colloid Kabushiki Kaisha | Sustained release capsule and method for preparing the same |
US6174529B1 (en) * | 1991-06-21 | 2001-01-16 | University Of Cincinnati | Oral therapy for the treatment of allergies and method of manufacture |
US6183808B1 (en) * | 1997-01-06 | 2001-02-06 | Bpsi Holdings, Inc. | Film coatings and film coating compositions based on dextrin |
US6348090B1 (en) * | 1997-01-06 | 2002-02-19 | Bpsi Holdings, Inc. | Film coatings and film coating compositions based on dextrin |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB734414A (en) | 1951-05-08 | 1955-08-03 | Hercules Powder Co Ltd | Improvements in or relating to preparation and use of finely-divided cellulose esters, ethers and mixed ether-esters |
US4060598A (en) | 1967-06-28 | 1977-11-29 | Boehringer Mannheim G.M.B.H. | Tablets coated with aqueous resin dispersions |
US3906086A (en) | 1971-07-19 | 1975-09-16 | Richard G Powers | Timed-release aspirin |
US3851574A (en) | 1972-12-26 | 1974-12-03 | Pillsbury Co | Heat and moisture activated savory coating system for popcorn |
US4112215A (en) | 1975-03-20 | 1978-09-05 | Rohm Gmbh | Copolymeric resin binder powders |
US4011392A (en) | 1975-09-02 | 1977-03-08 | The Sherwin-Williams Company | Mixed starch esters and the use thereof |
GB1594102A (en) | 1977-09-26 | 1981-07-30 | Sankyo Co | Ingestible coating compositions |
DE2820981C2 (en) | 1977-09-27 | 1995-07-06 | Colorcon | Pharmaceutical tablet and method for coloring a pharmaceutical tablet |
US4274830A (en) | 1977-09-27 | 1981-06-23 | Colorcon, Inc. | Colored medicinal tablet, natural color pigment and method for using the pigment in coloring food, drug and cosmetic products |
US4336244A (en) | 1977-09-27 | 1982-06-22 | Colorcon, Inc. | Colored medicinal tablet, natural color pigment and method for using the pigment in coloring food, drug and cosmetic products |
JPH027925B2 (en) | 1978-10-02 | 1990-02-21 | Purdue Research Foundation | |
US4307117A (en) | 1980-03-27 | 1981-12-22 | General Foods Corporation | Stabilized curcumin colorant |
US4340582A (en) | 1981-01-15 | 1982-07-20 | Abbott Laboratories | Erythromycin base tablets |
JPS57171428A (en) | 1981-04-13 | 1982-10-22 | Sankyo Co Ltd | Preparation of coated solid preparation |
US4790881A (en) | 1982-03-26 | 1988-12-13 | Warner-Lambert Company | Molded hydrophilic polymer |
US4514384A (en) | 1983-03-14 | 1985-04-30 | Gallina Damian J | Hemorrhoid treatment method |
DK62184D0 (en) | 1984-02-10 | 1984-02-10 | Benzon As Alfred | DIFFUSION COATED POLYDEPOT PREPARATION |
CA1239034A (en) | 1984-08-17 | 1988-07-12 | Kelly L. Smith | Delivery system |
EP0181966A1 (en) | 1984-11-13 | 1986-05-28 | Gist-Brocades N.V. | Compression-coated dispersible tablets |
DE3506276C1 (en) | 1985-02-22 | 1986-04-24 | Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring | Direct tableting |
GB8521494D0 (en) * | 1985-08-29 | 1985-10-02 | Zyma Sa | Controlled release tablet |
JPH0780754B2 (en) | 1986-08-06 | 1995-08-30 | エーザイ株式会社 | Multi-granular sustained-release tablet |
US4735659A (en) | 1986-08-18 | 1988-04-05 | Phillips Petroleum Company | Compositions and a process for preparing water dispersible polymers |
US4959227A (en) | 1987-02-17 | 1990-09-25 | Amer Moh S | High dietary fiber low lactose liquid food and a method of producing same |
US4820522A (en) | 1987-07-27 | 1989-04-11 | Mcneilab, Inc. | Oral sustained release acetaminophen formulation and process |
US4792452A (en) | 1987-07-28 | 1988-12-20 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
US5023083A (en) | 1987-09-23 | 1991-06-11 | William Drell | Azarbine composition |
US5068110A (en) | 1987-09-29 | 1991-11-26 | Warner-Lambert Company | Stabilization of enteric coated dosage form |
GB2212396A (en) | 1987-12-18 | 1989-07-26 | Procter & Gamble | Dietary supplement comprising calcium and delayed release coated iron |
US5472710A (en) | 1988-04-16 | 1995-12-05 | Schwarz Pharma Ag | Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture |
US4931285A (en) | 1988-04-28 | 1990-06-05 | Alza Corporation | Aqueous based pharmaceutical coating composition for dosage forms |
US5006362A (en) | 1988-05-09 | 1991-04-09 | Berwind Pharmaceutical Services, Inc. | Branding pharmaceutical dosage forms, food and confectionery products with aqueous ingestible inks |
US4877629A (en) | 1988-06-10 | 1989-10-31 | International Flavors & Fragrances Inc. | Process for preparing a coated food product |
US5268182A (en) | 1988-06-24 | 1993-12-07 | Abbott Laboratories | Sustained-release drug dosage units of terazosin |
IE63242B1 (en) | 1988-06-24 | 1995-04-05 | Abbott Lab | Pharmaceutical granules and tablets made therefrom |
US5169639A (en) | 1988-09-19 | 1992-12-08 | Edward Mendell Co., Inc. | Controlled release verapamil tablets |
US5128143A (en) | 1988-09-19 | 1992-07-07 | Edward Mendell Co., Inc. | Sustained release excipient and tablet formulation |
FR2653337B1 (en) | 1989-10-23 | 1992-02-07 | Dow Corning Sa | SUSTAINED RELEASE ELEMENT AND METHOD FOR MANUFACTURING THE SAME. |
JP2646851B2 (en) | 1989-10-26 | 1997-08-27 | 日本新薬株式会社 | Gastric retention formulation |
US5215756A (en) | 1989-12-22 | 1993-06-01 | Gole Dilip J | Preparation of pharmaceutical and other matrix systems by solid-state dissolution |
IE82916B1 (en) | 1990-11-02 | 2003-06-11 | Elan Corp Plc | Formulations and their use in the treatment of neurological diseases |
JP3078859B2 (en) | 1990-02-23 | 2000-08-21 | 武田薬品工業株式会社 | Coating agent for stable controlled release formulation |
US5368840A (en) | 1990-04-10 | 1994-11-29 | Imarx Pharmaceutical Corp. | Natural polymers as contrast media for magnetic resonance imaging |
IT1246382B (en) | 1990-04-17 | 1994-11-18 | Eurand Int | METHOD FOR THE TARGETED AND CONTROLLED DELIVERY OF DRUGS IN THE INTESTINE AND PARTICULARLY IN THE COLON |
WO1992012633A1 (en) | 1991-01-16 | 1992-08-06 | Fmc Corporation | Carrier for active agents, and solid dosage forms prepared therewith |
HU209564B (en) | 1991-01-30 | 1994-07-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing rapide tablets containing levodopa and carbidopa |
GB2253164B (en) | 1991-02-22 | 1994-10-05 | Hoechst Uk Ltd | Improvements in or relating to electrostatic coating of substrates of medicinal products |
US5332595A (en) * | 1991-03-18 | 1994-07-26 | Kraft General Foods, Inc. | Stable multiple emulsions comprising interfacial gelatinous layer, flavor-encapsulating multiple emulsions and low/no-fat food products comprising the same |
KR100221695B1 (en) | 1991-08-12 | 1999-09-15 | 그린 마틴, 브라이언 쥐 테슬리 | Pharmaceutical spheroid formulation |
US5225202A (en) | 1991-09-30 | 1993-07-06 | E. R. Squibb & Sons, Inc. | Enteric coated pharmaceutical compositions |
US5472712A (en) | 1991-12-24 | 1995-12-05 | Euroceltique, S.A. | Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
DE4200821A1 (en) | 1992-01-15 | 1993-07-22 | Bayer Ag | TASTE-MASKED PHARMACEUTICAL AGENTS |
US5262173A (en) | 1992-03-02 | 1993-11-16 | American Cyanamid Company | Pulsatile once-a-day delivery systems for minocycline |
IT1255522B (en) | 1992-09-24 | 1995-11-09 | Ubaldo Conte | COMPRESSED FOR THERAPEUTIC USE SUITABLE FOR SELLING ONE OR MORE ACTIVE SUBSTANCES WITH DIFFERENT SPEEDS |
IT1265092B1 (en) | 1993-05-31 | 1996-10-30 | Giuliani Spa | PREPARATION FOR USE AS A FOOD OR DIETARY SUPPLEMENT WITH TARGETED RELEASE IN THE COLON |
KR100337985B1 (en) | 1993-06-14 | 2002-11-23 | 얀센 파마슈티카 엔.브이. | Extended release film-coated tablet of astemizole and pseudoephedrine |
JP3017906B2 (en) | 1993-10-08 | 2000-03-13 | 信越化学工業株式会社 | Enteric coating agent dispersion |
FR2711525B1 (en) | 1993-10-29 | 1996-01-12 | Virbac Laboratoires | Galenic form for oral administration for animals, its preparation process and its applications. |
EP0746310B1 (en) | 1994-02-23 | 1998-11-18 | BM Research A/S | Controlled release composition |
US5458887A (en) | 1994-03-02 | 1995-10-17 | Andrx Pharmaceuticals, Inc. | Controlled release tablet formulation |
HU212428B (en) | 1994-05-13 | 1996-06-28 | Egyt Gyogyszervegyeszeti Gyar | Process to prepare pharmaceutical compositions containing gemfibrozyl |
US5523293A (en) | 1994-05-25 | 1996-06-04 | Iowa State University Research Foundation, Inc. | Soy protein-based thermoplastic composition for preparing molded articles |
US5529783A (en) | 1994-12-19 | 1996-06-25 | Mcneil-Ppc, Inc. | Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan |
US5547948A (en) | 1995-01-17 | 1996-08-20 | American Home Products Corporation | Controlled release of steroids from sugar coatings |
US5759577A (en) | 1995-01-17 | 1998-06-02 | American Home Products Corporation | Controlled release of steroids from sugar coatings |
KR100201352B1 (en) | 1995-03-16 | 1999-06-15 | 성재갑 | Single shot vaccine formulation |
JP3149125B2 (en) | 1995-05-01 | 2001-03-26 | 信越化学工業株式会社 | Base for coating solid enteric preparations |
US5840332A (en) | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
IT1282650B1 (en) | 1996-02-19 | 1998-03-31 | Jagotec Ag | PHARMACEUTICAL TABLET, CHARACTERIZED BY A HIGH INCREASE IN VOLUME IN CONTACT WITH BIOLOGICAL LIQUIDS |
US5849320A (en) | 1996-06-13 | 1998-12-15 | Novartis Corporation | Insecticidal seed coating |
FR2750864B1 (en) | 1996-07-10 | 1999-04-16 | Oreal | USE OF A POLYHOLOSIDE IN A COMPOSITION FOR STIMULATING IMMUNE DEFENSES, AND COMPOSITION COMPRISING SAME |
EP0852141A1 (en) | 1996-08-16 | 1998-07-08 | J.B. Chemicals & Pharmaceuticals Ltd. | Nifedipine containing pharmaceutical extended release composition and a process for the preparation thereof |
US5662732A (en) | 1996-08-09 | 1997-09-02 | Bpsi Holdings, Inc. | Polish composition |
US5851579A (en) | 1996-10-28 | 1998-12-22 | Eastman Chemical Company | Aqueous enteric coating compositions |
US5807580A (en) | 1996-10-30 | 1998-09-15 | Mcneil-Ppc, Inc. | Film coated tablet compositions having enhanced disintegration characteristics |
ES2137862B1 (en) | 1997-07-31 | 2000-09-16 | Intexim S A | ORAL PHARMACEUTICAL PREPARATION INCLUDING A COMPOUND OF ANTI-ULCER ACTIVITY AND PROCEDURE FOR ITS OBTAINING. |
NZ511442A (en) * | 1998-11-02 | 2003-02-28 | Elan Corp Plc | Multiparticulate modified release composition for multiple dosing of ADD patients with methylphenidate HCl |
US6274162B1 (en) | 2000-01-14 | 2001-08-14 | Bpsi Holdings, Inc. | Elegant film coating system |
-
2000
- 2000-10-26 US US09/696,780 patent/US6500462B1/en not_active Expired - Fee Related
- 2000-10-30 AU AU14434/01A patent/AU1443401A/en not_active Abandoned
- 2000-10-30 EP EP00976695A patent/EP1223920A1/en not_active Withdrawn
- 2000-10-30 IL IL14914900A patent/IL149149A0/en unknown
- 2000-10-30 WO PCT/US2000/029848 patent/WO2001032152A1/en not_active Application Discontinuation
- 2000-10-30 CN CNB008151210A patent/CN1198600C/en not_active Expired - Fee Related
- 2000-10-30 JP JP2001534357A patent/JP2003514778A/en active Pending
- 2000-10-30 TR TR2002/01111T patent/TR200201111T2/en unknown
- 2000-10-30 BR BR0014965-9A patent/BR0014965A/en not_active IP Right Cessation
-
2002
- 2002-11-27 US US10/306,649 patent/US20030129238A1/en not_active Abandoned
Patent Citations (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2881085A (en) * | 1953-11-09 | 1959-04-07 | Abbott Lab | Thin film coating for tablets and the like |
US3251824A (en) * | 1961-08-22 | 1966-05-17 | Fmc Corp | Method of preparing stable aqueous dispersion-forming cellulosic aggregates |
US3297535A (en) * | 1963-02-28 | 1967-01-10 | Hoffmann La Roche | Shellac tablet coating compositions and methods of preparation |
US3438797A (en) * | 1965-10-21 | 1969-04-15 | Jerry Allen Biddle Sr | Method of preparing pharmaceutical tablets |
US3503769A (en) * | 1966-09-08 | 1970-03-31 | Alginate Ind Ltd | Method of modifying alkylene glycol alginates |
US3573058A (en) * | 1967-01-30 | 1971-03-30 | Swift & Co | Microcrystalline cellulose compositions co-dried with hydrocolloids |
US3576663A (en) * | 1967-05-29 | 1971-04-27 | Colorcon | Coated tablet |
US3935326A (en) * | 1967-06-28 | 1976-01-27 | Boehringer Mannheim G.M.B.H. | Process for coating tablets with aqueous resin dispersions |
US3649302A (en) * | 1969-11-10 | 1972-03-14 | Cpc International Inc | Process of producing a ready-to-spread frosting |
US4009131A (en) * | 1972-01-17 | 1977-02-22 | The Lubrizol Corporation | Powder coating compositions and metal objects coated therewith |
US3957966A (en) * | 1972-05-19 | 1976-05-18 | Gaf Corporation | Stabilized vitamin food coatings |
US3860733A (en) * | 1972-07-31 | 1975-01-14 | Merck & Co Inc | Microencapsulated product |
US3883458A (en) * | 1973-02-02 | 1975-05-13 | Basf Ag | Flatting agents for coatings |
US3873694A (en) * | 1973-09-27 | 1975-03-25 | Cpc International Inc | Direct compression tabletting composition and pharmaceutical tablets produced therefrom |
US4015999A (en) * | 1975-01-08 | 1977-04-05 | Ciba-Geigy Corporation | Pigment compositions |
US4143163A (en) * | 1976-06-30 | 1979-03-06 | Maxfibe, Inc. | Coated fibrous cellulose product and process |
US4263334A (en) * | 1978-05-31 | 1981-04-21 | Fmc Corporation | Water dispersible cellulosic powder and method of making the same |
US4330338A (en) * | 1978-10-02 | 1982-05-18 | Purdue Research Foundation | Pharmaceutical coating composition, and preparation and dosages so coated |
US4324554A (en) * | 1978-11-09 | 1982-04-13 | Merck & Co., Inc. | Use of TKP as an antimigrant |
US4316884A (en) * | 1979-01-25 | 1982-02-23 | Adria Laboratories, Inc. | Sustained release pharmaceutical formulation |
US4257816A (en) * | 1979-09-17 | 1981-03-24 | Merck & Co., Inc. | Novel blend of algin, TKP, and guar gum |
US4250195A (en) * | 1979-09-24 | 1981-02-10 | Life Savers, Inc. | Method for applying soft flexible sugar coating to fresh chewing gum and coated chewing gum product |
US4252786A (en) * | 1979-11-16 | 1981-02-24 | E. R. Squibb & Sons, Inc. | Controlled release tablet |
US4432966A (en) * | 1979-12-10 | 1984-02-21 | Roussel-Uclaf | Compressed tablets for disintegration in the colon comprising an active ingredient containing nucleus coated with a first layer containing microcrystalline cellulose which is coated with an enteric organic polymer coating |
US4311717A (en) * | 1980-05-19 | 1982-01-19 | Fmc Corporation | Stabilizing agent for dry mix food products |
US4720378A (en) * | 1981-03-09 | 1988-01-19 | Imperial Chemical Industries Plc | Coated colored intagliated articles |
US4375468A (en) * | 1981-07-13 | 1983-03-01 | Verex Laboratories, Inc. | Constant order release aspirin composition and method of treating arthritis |
US4661162A (en) * | 1983-04-18 | 1987-04-28 | Sankyo Company, Limited | Enteric-soluble preparations |
US4505890A (en) * | 1983-06-30 | 1985-03-19 | E. R. Squibb & Sons, Inc. | Controlled release formulation and method |
US4513019A (en) * | 1983-07-06 | 1985-04-23 | Seppic | Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions |
US4576646A (en) * | 1983-07-06 | 1986-03-18 | Seppic | Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions |
US4665648A (en) * | 1983-07-06 | 1987-05-19 | Seppic Sa | Film-forming compositions for enveloping grains and seeds |
US4666703A (en) * | 1984-03-23 | 1987-05-19 | Ciba-Geigy Corporation | Storage-stable, quick-disintegrating pressed shapes containing pharmaceutical active substances |
US4725441A (en) * | 1984-07-24 | 1988-02-16 | Colorcon, Inc. | Maltodextrin coating |
US4643894A (en) * | 1984-07-24 | 1987-02-17 | Colorcon, Inc. | Maltodextrin coating |
US4828841A (en) * | 1984-07-24 | 1989-05-09 | Colorcon, Inc. | Maltodextrin coating |
US4645662A (en) * | 1984-07-26 | 1987-02-24 | Lion Corporation | Oral composition |
US4900557A (en) * | 1984-08-30 | 1990-02-13 | Troponwerke Gmbh & Co. Kg | Pellet formulation |
US4652313A (en) * | 1984-10-24 | 1987-03-24 | Crompton And Knowles Corporation | Aqueous lake pigment suspension |
US4636261A (en) * | 1984-10-24 | 1987-01-13 | Heinze Richard F | Dry lake system |
US4910028A (en) * | 1985-03-06 | 1990-03-20 | Griffith Laboratories U.S.A., Inc. | Honey coated and honey glazed roasted nuts and method for producing same |
US5008117A (en) * | 1985-05-08 | 1991-04-16 | Eurand Italia S.P.A. | Formulation for preparing extemporaneous homogeneous microcapsule suspension |
US4802924A (en) * | 1986-06-19 | 1989-02-07 | Colorcon, Inc. | Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products |
US4913919A (en) * | 1986-11-18 | 1990-04-03 | Frito-Lay, Inc. | Coating composition for comestible products |
US4981698A (en) * | 1986-12-23 | 1991-01-01 | Warner-Lambert Co. | Multiple encapsulated sweetener delivery system and method of preparation |
US5008113A (en) * | 1987-01-28 | 1991-04-16 | Shin-Etsu Chemical Co., Ltd. | Method for preparing film coated pharmaceutical preparations and method for improving properties thereof |
US5401515A (en) * | 1987-02-03 | 1995-03-28 | Dow Corning Corporation | Coated active agent-containing article |
US5310572A (en) * | 1987-02-03 | 1994-05-10 | Dow Corning Corporation | Process for forming a coated active agent-containing article |
US4981707A (en) * | 1987-03-24 | 1991-01-01 | Ogilvie Mills, Inc. | Dextrin-based food-grade adhesive including xanthan or carboxymethylcellulose or mixtures thereof |
US4892741A (en) * | 1987-06-24 | 1990-01-09 | Bayer Aktiengesellschaft | Press coated DHP tablets |
US4915954A (en) * | 1987-09-03 | 1990-04-10 | Alza Corporation | Dosage form for delivering a drug at two different rates |
US4814181A (en) * | 1987-09-03 | 1989-03-21 | Alza Corporation | Dosage form comprising fast agent delivery followed by slow agent delivery |
US5006513A (en) * | 1987-11-09 | 1991-04-09 | Miles Inc. | Antimycotic compositions of nikkomycin compounds and azole antimycotica |
US4816298A (en) * | 1987-11-27 | 1989-03-28 | The Dow Chemical Company | Method of making a granular, cold water dispersible coating composition |
US5009897A (en) * | 1988-06-24 | 1991-04-23 | Abbott Laboratories | Pharmaceutical granules and tablets made therefrom |
US4994276A (en) * | 1988-09-19 | 1991-02-19 | Edward Mendell Co., Inc. | Directly compressible sustained release excipient |
US5194464A (en) * | 1988-09-27 | 1993-03-16 | Takeda Chemical Industries, Ltd. | Enteric film and preparatoin thereof |
US5741600A (en) * | 1988-12-29 | 1998-04-21 | Deknatel Technology Corporation, Inc. | Absorbable coating and blend |
US5011701A (en) * | 1988-12-30 | 1991-04-30 | Kraft General Foods, Inc. | Low calorie food products having smooth, creamy, organoleptic characteristics |
US5192569A (en) * | 1989-05-26 | 1993-03-09 | Fmc Corporation | Fat-like bulking agent for aqueous foods comprising microcrystalline cellulose and a galactomannan gum |
US5202129A (en) * | 1989-08-04 | 1993-04-13 | Tanabe Seiyaku Co., Ltd. | Process for micronizing slightly-soluble drug |
US4983399A (en) * | 1989-10-18 | 1991-01-08 | Eastman Kodak Company | Direct compression carrier composition |
US5082684A (en) * | 1990-02-05 | 1992-01-21 | Pfizer Inc. | Low-calorie fat substitute |
US5393333A (en) * | 1990-03-27 | 1995-02-28 | Societe Anonyme Societe D'exploitation De Produits Pour Les Industries Chimiques S.E.P.P.I.C. | Film-forming product for coating solid forms, process for its manufacture and products coated with this film-forming product |
US5213738A (en) * | 1990-05-15 | 1993-05-25 | L. Perrigo Company | Method for making a capsule-shaped tablet |
US5089270A (en) * | 1990-05-15 | 1992-02-18 | L. Perrigo Company | Capsule-shaped tablet |
US5629003A (en) * | 1990-06-07 | 1997-05-13 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Rapidly disintegrating sheet-like presentations of multiple dosage units |
US5202137A (en) * | 1990-06-29 | 1993-04-13 | Berwind Pharmaceutical Services, Inc. | Method of inhibiting fat and oil migration from an oily substrate of a food product into a coating layer of a food product |
US5306506A (en) * | 1990-07-11 | 1994-04-26 | Eurand International S.P.A. | Pharmaceutical composition for rapid suspension in water |
US5480479A (en) * | 1990-12-20 | 1996-01-02 | Warner-Jenkinson Company, Inc. | Wet powder film-forming compositions |
US5098715A (en) * | 1990-12-20 | 1992-03-24 | Burroughs Wellcome Co. | Flavored film-coated tablet |
US5591455A (en) * | 1990-12-20 | 1997-01-07 | Warner-Jenkinson Company, Inc. | Wet powder film-forming compositions |
US5514384A (en) * | 1990-12-20 | 1996-05-07 | Warner-Jenkins Co. | Wet powder film-forming compositions |
US5630871A (en) * | 1991-01-17 | 1997-05-20 | Berwind Pharmaceutical Services, Inc. | Film coatings and film coating compositions based on cellulosic polymers and lactose |
US5743947A (en) * | 1991-01-17 | 1998-04-28 | Berwind Pharmaceutical Services, Inc. | Film coatings and film coating compositions based on cellulosic polymers and lacttose |
US5389129A (en) * | 1991-05-29 | 1995-02-14 | Berwind Pharmaceutical Services, Inc. | Wax polish composition |
US6174529B1 (en) * | 1991-06-21 | 2001-01-16 | University Of Cincinnati | Oral therapy for the treatment of allergies and method of manufacture |
US5288501A (en) * | 1991-07-04 | 1994-02-22 | Merz + Co. Gmbh & Co. | Mechanically-stable, readily-disintegratable tablets made of small preformed particles containing active ingredients |
US5209942A (en) * | 1991-11-27 | 1993-05-11 | Thomas J. Lipton, Co., Division Of Conopco, Inc. | Low fat/no fat salad dressing having mimetic functional properties fat and a process therefor |
US5409715A (en) * | 1992-04-21 | 1995-04-25 | Wm. Wrigley Jr. Company | Use of edible film to prolong chewing gum shelf life |
US5286502A (en) * | 1992-04-21 | 1994-02-15 | Wm. Wrigley Jr. Company | Use of edible film to prolong chewing gum shelf life |
US5286510A (en) * | 1992-10-07 | 1994-02-15 | Thomas J. Lipton Co., Division Of Conopco, Inc. | Fat mimetic containing salad dressing and process therefor |
US5595762A (en) * | 1992-11-30 | 1997-01-21 | Laboratoires Virbac | Stabilized pulverulent active agents, compositions containing them, process for obtaining them and their applications |
US5595592A (en) * | 1993-02-24 | 1997-01-21 | Warner-Jenkinson Company, Inc. | Dye compositions and methods for film coating tablets and the like |
US5512314A (en) * | 1993-02-24 | 1996-04-30 | Warner-Jenkinson Company | Dye compositions and methods for film coating tablets and the like |
US5411746A (en) * | 1993-02-24 | 1995-05-02 | Warner-Jenkinson Company, Inc. | Dye compositions and methods for film coating tablets and the like |
US5514435A (en) * | 1993-03-10 | 1996-05-07 | New Oji Paper Co., Ltd. | Adhesive sheet |
US5624612A (en) * | 1993-08-25 | 1997-04-29 | Fmc Corporation | Nonaggregating hydrocolloid microparticulates, intermediates therefor, and processes for their preparation |
US5512092A (en) * | 1994-04-15 | 1996-04-30 | Shin-Etsu Chemical Co., Ltd. | Method for preparing aqueous emulsion for coating solid pharmaceutical preparations |
US5885617A (en) * | 1994-07-12 | 1999-03-23 | Bpsi Holdings, Inc. | Moisture barrier film coating composition, method, and coated form |
US5733575A (en) * | 1994-10-07 | 1998-03-31 | Bpsi Holdings, Inc. | Enteric film coating compositions, method of coating therewith, and coated forms |
US6039976A (en) * | 1994-10-07 | 2000-03-21 | Bpsi Holdings, Inc. | Enteric film coating compositions, method of coating therewith, and coated forms |
US5756123A (en) * | 1994-12-01 | 1998-05-26 | Japan Elanco Co., Ltd. | Capsule shell |
US5882707A (en) * | 1996-01-05 | 1999-03-16 | Bpsi Holdings, Inc. | Method of coating an edible substrate with sugar/syrup or sugarless solutions containing dry color concentrate |
US5876739A (en) * | 1996-06-13 | 1999-03-02 | Novartis Ag | Insecticidal seed coating |
US5709896A (en) * | 1996-06-18 | 1998-01-20 | Fmc Corporation | Reduced-fat food dispersions and method of preparing |
US6183808B1 (en) * | 1997-01-06 | 2001-02-06 | Bpsi Holdings, Inc. | Film coatings and film coating compositions based on dextrin |
US6348090B1 (en) * | 1997-01-06 | 2002-02-19 | Bpsi Holdings, Inc. | Film coatings and film coating compositions based on dextrin |
US6030641A (en) * | 1997-06-03 | 2000-02-29 | Uni Colloid Kabushiki Kaisha | Sustained release capsule and method for preparing the same |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8801847B2 (en) | 2002-05-14 | 2014-08-12 | Fmc Corporation | Microcrystalline cellulose compositions |
US8636011B2 (en) | 2003-11-07 | 2014-01-28 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
US10945454B2 (en) | 2003-11-07 | 2021-03-16 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
US10765140B2 (en) | 2003-11-07 | 2020-09-08 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
US10098376B2 (en) | 2003-11-07 | 2018-10-16 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
US8469036B2 (en) | 2003-11-07 | 2013-06-25 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
US20070026063A1 (en) * | 2005-07-29 | 2007-02-01 | Shin-Etsu Chemical Co., Ltd. | Composition for coating comprising low-substituted cellulose ether and coated preparation having unpleasant taste masked |
US8795722B2 (en) | 2005-07-29 | 2014-08-05 | Shin-Etsu Chemical Co., Ltd. | Composition for coating comprising low-substituted cellulose ether and coated preparation having unpleasant taste masked |
US7879382B2 (en) | 2005-09-30 | 2011-02-01 | Fmc Corporation | Stabilizers and compositions and products comprising same |
US20070128333A1 (en) * | 2005-09-30 | 2007-06-07 | Tuason Domingo C | Stabilizers and Compositions and Products Comprising Same |
WO2007087188A3 (en) * | 2006-01-20 | 2007-12-13 | Merck & Co Inc | Taste-masked tablets and granules |
WO2007087188A2 (en) * | 2006-01-20 | 2007-08-02 | Merck & Co., Inc. | Taste-masked tablets and granules |
US7998505B2 (en) | 2006-10-27 | 2011-08-16 | Fmc Corporation | Dry granulation binders, products, and use thereof |
US20080213360A1 (en) * | 2006-10-27 | 2008-09-04 | Fmc Corporation | Dry granulation binders, products, and use thereof |
US9055757B2 (en) | 2011-10-05 | 2015-06-16 | Fmc Corporation | Stabilizer composition of co-attrited microcrystalline cellulose and carboxymethylcellulose, method for making, and uses |
US9826763B2 (en) | 2011-10-05 | 2017-11-28 | Fmc Corporation | Stabilizer composition of microcrystalline cellulose and carboxymethylcellulose, method for making, and uses |
US10299501B2 (en) | 2011-10-05 | 2019-05-28 | DuPont Nutrition USA, Inc. | Stabilizer composition of microcrystalline cellulose and carboxymethylcellulose, method for making, and uses |
US8927609B2 (en) | 2011-12-09 | 2015-01-06 | Fmc Corporation | Co-attrited stabilizer composition |
US9828493B2 (en) | 2011-12-09 | 2017-11-28 | Fmc Corporation | Co-attrited stabilizer composition having superior gel strength |
Also Published As
Publication number | Publication date |
---|---|
CN1384737A (en) | 2002-12-11 |
JP2003514778A (en) | 2003-04-22 |
TR200201111T2 (en) | 2003-01-21 |
BR0014965A (en) | 2002-10-01 |
US6500462B1 (en) | 2002-12-31 |
AU1443401A (en) | 2001-05-14 |
IL149149A0 (en) | 2002-11-10 |
WO2001032152A1 (en) | 2001-05-10 |
EP1223920A1 (en) | 2002-07-24 |
CN1198600C (en) | 2005-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6500462B1 (en) | Edible MCC/PGA coating composition | |
US6709713B2 (en) | Edible coating composition | |
US6932861B2 (en) | Edible PGA coating composition | |
US6723342B1 (en) | Edible coating composition | |
US6699315B2 (en) | Edible PGA coating composition | |
US8123849B2 (en) | Aqueous film coating composition containing sodium alginate and preparation thereof | |
WO2001032150A1 (en) | Edible coating composition | |
US20050196445A1 (en) | Edible microcrystalline cellulose and carrageenan coating composition | |
MXPA01007782A (en) | Edible coating composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |